WIA
DMAC icon

World Investment Advisors’s DiaMedica Therapeutics DMAC Stock Holding History

World Investment Advisors’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$250K Hold
36,975
– – ﹤0.01% 1362
2025
Q4 		$294K Buy
36,975
+2,650
+8% +$19.8K ﹤0.01% 1196
2025
Q3 		$236K Buy
34,325
+2,350
+7% +$12.7K ﹤0.01% 1094
2025
Q2 		$125K Buy
31,975
+6,325
+25% +$24.7K ﹤0.01% 1107
2025
Q1 		$97.2K Buy
25,650
+3,735
+17% +$21.4K ﹤0.01% 1036
2024
Q4 		$119K Buy
+21,915
New +$103K ﹤0.01% 987

Other funds holding DMAC

CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

World Investment Advisors's DMAC Position: Q1 2026 in Review

World Investment Advisors held its DiaMedica Therapeutics (DMAC) position steady in Q1 2026 at 36,975 shares worth $250K. The position accounts for ﹤0.01% of the portfolio, ranked #1362.

World Investment Advisors first reported a position in DMAC in Q4 2024 and has held it in 6 quarters since. The position peaked at $294K in Q4 2025. 98 funds tracked by Wall St. Rank hold DMAC as of Q1 2026.

  • World Investment Advisors held 36,975 shares of DiaMedica Therapeutics worth $250K as of Q1 2026.
  • World Investment Advisors left its DiaMedica Therapeutics share count unchanged in Q1 2026.
  • DiaMedica Therapeutics made up ﹤0.01% of World Investment Advisors's portfolio in Q1 2026, its #1362 holding.
  • World Investment Advisors first reported a position in DiaMedica Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • World Investment Advisors's DiaMedica Therapeutics position peaked at $294K in Q4 2025.
  • 98 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q1 2026.

Based on World Investment Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.